

Search

EN

Back

Johnson & Johnson Reveals New Depression Drug Data for CAPLYTA and SPRAVATO

Back

Stock NewsThemesJohnson & Johnson Reveals New Depression Drug Data for CAPLYTA and SPRAVATO

Johnson & Johnson Reveals New Depression Drug Data for CAPLYTA and SPRAVATO

Edgen Stock·Jan 13 2026, 14:49

Share to

Share to

Copy link

source:

[1] Johnson & Johnson elevates leadership in depression with new data at 2026 American College of Neuropsychopharmacology Annual Meeting

Recommend

Agriculture ETFs Break Out on Fertilizer Supply FearsMar 06 2026, 16:17 Tango Therapeutics Stock Hits Record High on Erasca Cancer Trial DealMar 06 2026, 16:02 Parker-Hannifin Stock Climbs 53% on Aerospace DemandMar 06 2026, 16:01

Hot News

Rio Tinto Revenue Hits $57.6B on Record Iron, Copper OutputMar 06 2026, 16:32

AppLovin Stock Gains 5.3% To Reach $508Mar 06 2026, 16:30

SoundHound Shares Fall as Losses Eclipse 59% Revenue GrowthMar 06 2026, 16:30

CMA CGM's Q4 Profit Collapses to Zero From $1.53 BillionMar 06 2026, 16:27

Features

AI Copilot for Stock & Crypto

Price Prediction

Fundraise Tracker

Crypto Comparison

Resources

Market

Terms of Use Privacy Policy Sitemap

© 2026 Finture Development Limited. All rights reserved